Depression circumstantially related to the administration of finasteride for androgenetic alopecia

Journal of Dermatology

Volumn 29, Issue 10, 2002, Pages 665-669

  Altomare, Gianfranco ^a   Capella, Giovanni Luigi ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Alopecia; Depression; Drug reaction; Finasteride; Mood disorder

Indexed keywords

FINASTERIDE;

ADOLESCENT; ADULT; ANOREXIA; ANXIETY; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN RELATION; HYPERSOMNIA; INSOMNIA; MALE; MALE TYPE ALOPECIA; MOOD DISORDER;

EID: 0036808650     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2002.tb00200.x     Document Type: Article

References (15)

1. McClellan KJ, Markham A: Finasteride. A review of its use in male pattern hair loss, Drugs, 57: 111-126, 1999.
2. Hamilton JB: Patterned long hair in man: Types and incidence, Ann N Y Acad Sci, 53: 708-714, 1951.
3. Ludwig E: Classification of the types of androgenetic alopecia (common baldness) arising in the female sex, Br J Dermatol, 97: 249-256, 1977.
4. Norwood OTT: Male pattern baldness. Classification and incidence, South Med J, 68: 1359-1370; 1975.
5. Ciotta L, Cianci A, Calogero AE, et al: Clinical and endocrine effects of finasteride, a 5α-reductase inhibitor, in women with idiopathic hirsutism, Fertil Steril, 64: 299-306, 1995.
6. American Psychiatric Association: DSM-IV-TR. Manuale Diagnostico e Statistico dei Disturbi Mentali, Text Revision (Italian translation edited by Andreoli V, Cassano GB, Rossi R), 4th ed, Masson, Milan, 2001, pp436-440.
7. American Psychiatric Association: DSM-IV-TR. Manuale diagnostico e statistico dei disturbi mentali. Text revision (Italian translation edited by Andreoli V, Cassano GB, Rossi R), 4th ed, Masson, Milan, 2001, pp794-795.
8. Brussels JA, La Fond Cantzlaar G: Chambers's Dictionary of Psychiatry, W&R Chambers Ltd, Edinburgh-London, 1967, pp67-68.
9. Brosig B: The"Dorian Gray syndrome": Psychodynamic need for hair growth restores and other "fountains of youth", Int J Clin Pharm Ther, 39: 279-283, 2001.
10. Diamanti-Kandarakis E: Current aspects of antiandrogen therapy in women, Curr Pharmaceut Design, 5: 707-723, 1999.
11. Shaw JC: Hormonal therapy in dermatology, Dermatol Clin, 19: 169-178, 2001.
12. Norwood OTT, Lehr B: Female androgenetic alopecia: A separate entity?, Dermatol Surg, 26: 679-682, 2000.
13. Price VH, Roberts JL, Hordinsky M, et al: Lack of efficacy of finasteride in postemenopausal women with androgenetic alopecia, J Am Acad Dermatol, 43: 768-776, 2000.
14. Lu S, Simon NG, Wang Y, et al: Neural androgen receptor regulation: Effects of androgen and antiandrogen, J Neurobiol, 41: 505-512, 1999.
15. Steckelbroeck S, Watzka M, Reichelt R, et al: Characterization of the 5α-reductase-3α-hydroxysteroid dehydrogenase complex in the human brain, J Clin Endocr Metab, 86: 1324-1331, 2001.